CLOs on the Move

Universal Pediatrics

www.universalpediatrics.com

 
Universal Pediatrics is a company that provides in-home healthcare and private duty nursing services for children and young adults with serious medical conditions.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Accugen Laboratories Inc

Accugen Laboratories Inc is a Willowbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Group Health

Group Health is a Surrey, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bronx AIDS Services

Bronx AIDS Services (BAS), an AIDS service organization, helps more than 25,000 Bronx residents each year with an array of free services designed to meet the needs of this ethnically and culturally diverse community. Our services include: Extensive

Eleven Biotherapeutics

"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."

Alluvion Health

Alluvion Health is a not-for-profit Federally Qualified Health Center that provides high quality, cost-effective, comprehensive primary and preventive medical, dental, and behavioral health care to individuals regardless of income, insurance, or abilit...